异动解读 | 诺和诺德终止合作,Hims & Hers Health盘中大涨5.08%

异动解读
Jun 27, 2025

远程医疗公司Hims & Hers Health Inc.(股票代码:HIMS)今日盘中股价大涨5.08%,引起市场广泛关注。这一突然的股价上涨似乎与该公司近期的业务变动有关。

据报道,丹麦制药巨头诺和诺德(Novo Nordisk)近日终止了与Hims & Hers Health的合作协议。该协议原本允许Hims & Hers通过诺和诺德的NovoCare Pharmacy平台直接销售其明星减肥药Wegovy。诺和诺德表示,尽管Wegovy的供应短缺问题已得到缓解,但Hims & Hers去年推出的低价复合版本仍未符合联邦相关法规。

这一消息引发了市场对Hims & Hers未来业务发展的讨论。尽管失去了与诺和诺德的合作,但投资者似乎对公司的前景持乐观态度。分析人士认为,这可能是因为投资者预期Hims & Hers将寻求新的合作伙伴或开发自己的替代产品,从而在竞争激烈的远程医疗和处方药市场中保持竞争力。然而,具体的长期影响还有待进一步观察。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10